These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 12753767)
21. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. Pralhad T; Rajendrakumar K J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147 [TBL] [Abstract][Full Text] [Related]
22. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds. Fernandes CM; Teresa Vieira M; Veiga FJ Eur J Pharm Sci; 2002 Feb; 15(1):79-88. PubMed ID: 11803134 [TBL] [Abstract][Full Text] [Related]
24. Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique. Mihajlovic T; Kachrimanis K; Graovac A; Djuric Z; Ibric S AAPS PharmSciTech; 2012 Jun; 13(2):623-31. PubMed ID: 22535520 [TBL] [Abstract][Full Text] [Related]
25. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity. Yurtdaş-Kırımlıoğlu G Drug Dev Ind Pharm; 2021 Aug; 47(8):1261-1278. PubMed ID: 34606394 [TBL] [Abstract][Full Text] [Related]
26. Bioavailability enhancement of poorly water soluble and weakly acidic new chemical entity with 2-hydroxy propyl-beta-cyclodextrin: selection of meglumine, a polyhydroxy base, as a novel ternary component. Basavaraj S; Sihorkar V; Shantha Kumar TR; Sundaramurthi P; Srinivas NR; Venkatesh P; Ramesh M; Kumar Singh S Pharm Dev Technol; 2006; 11(4):443-51. PubMed ID: 17101515 [TBL] [Abstract][Full Text] [Related]
27. Binary and ternary complexes of norfloxacin to improve the solubility of the active pharmaceutical ingredient. Ponce-Ponte M; Aloisio C; Romero-Guerra DM; Gracia-Vásquez S; Garnero C; Longhi M Ther Deliv; 2018 Sep; 9(9):639-652. PubMed ID: 30189811 [TBL] [Abstract][Full Text] [Related]
28. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin. Spamer E; Müller DG; Wessels PL; Venter JP Eur J Pharm Sci; 2002 Sep; 16(4-5):247-53. PubMed ID: 12208454 [TBL] [Abstract][Full Text] [Related]
29. Solid-state characterization and in vitro dissolution behavior of lorazepam: Hydroxypropyl-β-cyclodextrin inclusion complex. Patel R; Patel M Drug Discov Ther; 2010 Dec; 4(6):442-52. PubMed ID: 22491310 [TBL] [Abstract][Full Text] [Related]
30. Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug. Aloisio C; Gomes de Oliveira A; Longhi M Drug Dev Ind Pharm; 2014 Jul; 40(7):919-28. PubMed ID: 23627444 [TBL] [Abstract][Full Text] [Related]
31. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin. Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357 [TBL] [Abstract][Full Text] [Related]
34. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes. Jambhekar S; Casella R; Maher T Int J Pharm; 2004 Feb; 270(1-2):149-66. PubMed ID: 14726131 [TBL] [Abstract][Full Text] [Related]
35. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state. Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856 [TBL] [Abstract][Full Text] [Related]
36. Enhanced antibacterial activity of levofloxacin/hydroxypropyl-β-cyclodextrin inclusion complex: In vitro and in vivo evaluation. Li Y; Zhou J; Gu J; Shao Q; Chen Y Colloids Surf B Biointerfaces; 2022 Jul; 215():112514. PubMed ID: 35490541 [TBL] [Abstract][Full Text] [Related]
37. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin. Bhargava S; Agrawal GP Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545 [TBL] [Abstract][Full Text] [Related]
38. Binary inclusion complexes of diflunisal with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: Preparation and characterization. Bashir M; Syed HK; Asghar S; Irfan M; Aslam N; Iqbal MS; Khan IU; Shah PA; Khan NR; Ahmad J; Saleem M; Asif M Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2307-2315. PubMed ID: 33832905 [TBL] [Abstract][Full Text] [Related]
39. Preparation, characterization, and antifungal property of the inclusion complex of Litsea cubeba essential oil/hydroxypropyl-β-cyclodextrin and its application in preservation of Shatang mandarin. Li X; Li G; Shan Y; Zhu X J Food Sci; 2022 Oct; 87(10):4714-4724. PubMed ID: 36121061 [TBL] [Abstract][Full Text] [Related]
40. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]